Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 13Breast 9Genitourinary 7Thoracic 5Head & Neck 3CNS 3Gynecologic 2Dermatologic 1

Conditions

Ovarian Neoplasms 3160Uterine Cervical Neoplasms 2182Endometrial Neoplasms 1330Breast Neoplasms 816Fallopian Tube Neoplasms 807Carcinoma, Ovarian Epithelial 771Neoplasms 540Colorectal Neoplasms 437Carcinoma, Non-Small-Cell Lung 418Uterine Cervical Dysplasia 376Pancreatic Neoplasms 363Stomach Neoplasms 353Prostatic Neoplasms 317Lung Neoplasms 315Melanoma 289Uterine Neoplasms 239Peritoneal Neoplasms 238Neoplasm Metastasis 236Vulvar Neoplasms 229Urinary Bladder Neoplasms 225Esophageal Neoplasms 224Head and Neck Neoplasms 221Sarcoma 218Carcinoma, Renal Cell 213Recurrence 212Colonic Neoplasms 210Papillomavirus Infections 205Triple Negative Breast Neoplasms 189Squamous Cell Carcinoma of Head and Neck 175Vaginal Neoplasms 147

Interventions

Radiotherapy 2TP protocol 1Paclitaxel 1Cisplatin 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Neoplasm Recurrence, Local × Gynecologic × Clear all
NCT06532539 2026-04-24

Cadonilimab With Chemoradiation for Recurrent and Oligometastatic Endometrial Carcinoma

Shandong Cancer Hospital and Institute

Phase 2 Recruiting
30 enrolled
Gynecologic

Neoplasm Metastasis, Neoplasm Recurrence, Local, Neoplasms, Endometrial Neoplasms

NCT06942416 2025-04-24

Iparomlimab and Tuvonralimab With Chemoradiation for the Treatment of Locally Recurrent and Oligometastatic Cervical Cancer

Shandong Cancer Hospital and Institute

Phase 2 Recruiting
36 enrolled
Gynecologic

Uterine Cervical Neoplasms, Neoplasm Recurrence, Local, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡